Both parents and children in the study were motivated by the prospect of accessing the latest technology, specifically an insulin pump and continuous blood glucose monitoring device, which were offered to both the intervention and control groups within one week after diabetes diagnosis. The gene discussed is INS; the disease is diabetes mellitus.